
New health technology assessment
Korea’s government review of whether a newly developed medical procedure is safe and effective for a defined use.
Under the Medical Service Act, the Ministry of Health and Welfare assesses the safety and effectiveness of newly developed medical technologies, after review by a new health technology assessment committee. Results can be published.
This is a different route from the Advanced Regenerative Bio Act. Some same-day procedures have been assessed as medical technologies for specific conditions, such as one bone marrow procedure for certain cases of knee osteoarthritis. The Medical Service Act also bars clinics from advertising a new health technology that has not been assessed.
Practical check: ask whether the procedure you are offered has been assessed, and whether your condition falls within the assessed use.
Related terms
- Bone marrow aspirate concentrate (BMAC)
- Bone marrow drawn from your hip bone and concentrated in a centrifuge on the same day, then injected, often into a joint.
- Knee osteoarthritis
- A long-term condition in which the cartilage cushioning the knee slowly wears down, causing pain, stiffness and swelling.
- Advanced Regenerative Bio Act
- Korea’s main law on regenerative treatments that use human cells, and on medicines made from cells, genes or engineered tissue.
- Korean medical advertising rules
- Korean laws that limit what hospitals and clinics may say when they advertise treatments.
Source: Medical Service Act (Korean, Korea Law Information Center)
Read next
Not sure where to start?
Send your question and any X-ray or MRI report you have. COMEDI, the registered coordinator that runs this guide, replies in writing and can ask a clinic for its written answer and an itemised quote.